Cargando…
Targeting the IGF-Axis in Cultured Pediatric High-Grade Glioma Cells Inhibits Cell Cycle Progression and Survival
Pediatric high-grade gliomas (pHGG) accounts for approximately 8–12% of primary brain tumors in children. Prognosis is poor, with a median survival of 9–15 months. Insulin-like growth factor 1-receptor (IGF-1R) gene amplifications have been identified in high-grade gliomas and may contribute to its...
Autores principales: | Chen, Yinhsuan Michely, Leibovitch, Matthew, Zeinieh, Michele, Jabado, Nada, Brodt, Pnina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964639/ https://www.ncbi.nlm.nih.gov/pubmed/37259440 http://dx.doi.org/10.3390/ph16020297 |
Ejemplares similares
-
Targeting the IGF-Axis for Cancer Therapy: Development and Validation of an IGF-Trap as a Potential Drug
por: Chen, Yinhsuan Michely, et al.
Publicado: (2020) -
Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
por: Tsui, Jennifer, et al.
Publicado: (2021) -
Glioma Cells With Genetically Engineered IGF-I Receptor Downregulation Can Persist in the Brain in a Dormant State
por: Samani, Amir A., et al.
Publicado: (2020) -
Surviving host innate immunity: Cancer cells can turn a deadly assault into an advantage
por: Brodt, Pnina
Publicado: (2012) -
HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA
por: Dubois, Frank, et al.
Publicado: (2020)